Principal Financial Group Inc Mirum Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$23.57 - $34.85 $31,253 - $46,211	-1,326 Reduced 15.92%	7,001 $239,000
Q1 2024 Apr 29, 2024	BUY	$24.92 - $30.02 $2,591 - $3,122	104 Added 1.26%	8,327 $209,000
Q4 2023 Feb 07, 2024	SELL	$27.14 - $34.93 $2,388 - $3,073	-88 Reduced 1.06%	8,223 $242,000
Q3 2023 Nov 02, 2023	SELL	$24.63 - $32.85 $7,807 - $10,413	-317 Reduced 3.67%	8,311 $262,000
Q2 2023 Aug 07, 2023	BUY	$23.51 - $30.09 $202,844 - $259,616	8,628 New	8,628 $223,000
Q2 2022 Aug 10, 2022	BUY	$18.42 - $27.5 $644,165 - $961,702	34,971 New	34,971 $681,000

195

54M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.92B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.